|
RAPH Raphael Pharmaceutical Inc 1415397 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-223,000.00 |
| Balance Sheet |
|
Current Assets
|
$6,000.00 |
|
Assets
|
$7,000.00 |
|
Current Liabilities
|
$1,892,000.00 |
|
Equity
|
$-1,885,000.00 |
|
Shares Out
|
20176418.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-44,000.00 |
|
Investing Cash Flow
|
$-1,000.00 |
| Market Analysis |
Market Cap
|
$28,246,985.20 |
|
Price
|
$1.40 |
|
PB
|
0.44 |
|
EPS
|
0.01 |
|
FCF
|
$-45,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:57 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RAPH documents filed with the SEC.
RAPH Filings
Clear
